Oncoclinicas do Brasil - Asset Resilience Ratio

Latest as of September 2025: 5.34%

Oncoclinicas do Brasil (ONCO3) has an Asset Resilience Ratio of 5.34% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Also explore Oncoclinicas do Brasil asset portfolio for the complete picture of this company's asset base.

Liquid Assets

R$439.31 Million
≈ $86.20 Million USD Cash + Short-term Investments

Total Assets

R$8.22 Billion
≈ $1.61 Billion USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2013–2024)

This chart shows how Oncoclinicas do Brasil's Asset Resilience Ratio has changed over time. See how leveraged is Oncoclinicas do Brasil's balance sheet to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Oncoclinicas do Brasil's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see how much is Oncoclinicas do Brasil worth.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents R$162.75 Million 1.98%
Short-term Investments R$276.55 Million 3.36%
Total Liquid Assets R$439.31 Million 5.34%

Asset Resilience Insights

  • Limited Liquidity: Oncoclinicas do Brasil maintains only 5.34% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Oncoclinicas do Brasil Industry Peers by Asset Resilience Ratio

Compare Oncoclinicas do Brasil's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Ramsay Health Care Ltd
AU:RHC
Medical Care Facilities 3.49%
Mitra Keluarga Karyasehat Tbk PT
JK:MIKA
Medical Care Facilities 9.01%
Pihlajalinna Oy
HE:PIHLIS
Medical Care Facilities 5.13%
Max India Limited
NSE:MAXIND
Medical Care Facilities 17.16%
Regis Healthcare Ltd
AU:REG
Medical Care Facilities 2.29%
Oceania Healthcare Ltd
AU:OCA
Medical Care Facilities 0.01%
Pacific Smiles Group Ltd
AU:PSQ
Medical Care Facilities 10.35%
Freedom Care Group Holdings Ltd
AU:FCG
Medical Care Facilities 0.39%

Annual Asset Resilience Ratio for Oncoclinicas do Brasil (2013–2024)

The table below shows the annual Asset Resilience Ratio data for Oncoclinicas do Brasil.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 16.16% R$1.81 Billion
≈ $355.20 Million
R$11.20 Billion
≈ $2.20 Billion
+8.51pp
2023-12-31 7.65% R$702.41 Million
≈ $137.83 Million
R$9.18 Billion
≈ $1.80 Billion
-5.09pp
2022-12-31 12.74% R$1.05 Billion
≈ $205.47 Million
R$8.22 Billion
≈ $1.61 Billion
-19.85pp
2021-12-31 32.59% R$1.97 Billion
≈ $385.80 Million
R$6.03 Billion
≈ $1.18 Billion
+9.89pp
2020-12-31 22.70% R$770.34 Million
≈ $151.16 Million
R$3.39 Billion
≈ $665.86 Million
+3.84pp
2019-12-31 18.86% R$397.97 Million
≈ $78.09 Million
R$2.11 Billion
≈ $414.07 Million
+7.54pp
2018-12-31 11.32% R$152.65 Million
≈ $29.95 Million
R$1.35 Billion
≈ $264.56 Million
+11.28pp
2015-12-31 0.04% R$224.00K
≈ $43.95K
R$522.46 Million
≈ $102.52 Million
-1.32pp
2014-12-31 1.36% R$4.91 Million
≈ $962.84K
R$360.93 Million
≈ $70.82 Million
+0.41pp
2013-12-31 0.95% R$3.05 Million
≈ $599.25K
R$320.43 Million
≈ $62.87 Million
--
pp = percentage points

About Oncoclinicas do Brasil

SA:ONCO3 Brazil Medical Care Facilities
Market Cap
$301.69 Million
R$1.54 Billion BRL
Market Cap Rank
#15006 Global
#143 in Brazil
Share Price
R$1.75
Change (1 day)
+19.86%
52-Week Range
R$1.04 - R$5.72
All Time High
R$19.24
About

Oncoclínicas do Brasil Serviços Médicos S.A., together with its subsidiaries, provides oncology, hematology, radiotherapy, and genomics healthcare services in Latin America. The company offers treatment services, including radiotherapy, hormone therapy, immunotherapy, port-a-cath, palliative care, target therapy, breast cancer hormone therapy, bone marrow transplant, non-oncological infusions, ch… Read more